ArticleNeuro-oncology advances

The impact of different volumetric thresholds to determine progressive disease in patients with recurrent glioblastoma treated with bevacizumab.

Renske Gahrmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.